Skip to main content

Share story

Infrastructure

Tesla and SpaceX will invest $16.8B to start building 'Terafab' chip factory in Texas

Tesla and SpaceX will invest $16.8B to start building 'Terafab' chip factory in Texas Image: Primary
Tesla and SpaceX said Thursday they will invest $16.8 billion to start building a joint advanced chip factory called Terafab in Grimes County, Texas, the companies announced. The facility is planned to cover more than 100 million square feet of manufacturing space and employ at least 3,000 people from Grimes and nearby Brazos County, according to SpaceX. Elon Musk, CEO of both companies, wrote in a post on Thursday that the factory will be the largest and most valuable building on Earth by far. A post on SpaceX's website said the facility will bridge the divide between current global chip supply and future compute demand. Intel has said it will contribute to the Terafab project, though it has not detailed its exact contributions. SpaceX said it is committing to the use of water from the local Gibbons Creek Reservoir instead of local groundwater. The announcement followed a heavily attended county meeting on Wednesday where hundreds of residents raised concerns about millions of dollars in tax breaks awarded to the project and a lack of transparency.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from techcrunch.com, tomshardware.com, usatoday.com and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...